Seoul, South Korea

Kye Shin Park

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Diatech Korea Co., Ltd., Dk Holdings Company, Ltd, Hyundai Electronics Industries Co. Ltd.. Active years: 1991-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kye Shin Park. Retrieved from https://idiyas.com/inventor/kye-shin-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1991-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Kye Shin Park

Introduction

Kye Shin Park, a distinguished inventor based in Seoul, South Korea, has made significant contributions to the field of biomedical technology. With three patents to his name, his work focuses on advancing methods for detecting antibiotic resistance and developing innovative cancer treatment options.

Latest Patents

Kye Shin Park's latest inventions demonstrate his commitment to improving healthcare outcomes. One of his notable patents involves the "Direct detection of the active form of beta-lactam-hydrolysing enzymes by using mass spectrophotometry." This invention introduces a method for directly detecting antibiotic resistance in microorganisms using mass spectrometry. The approach simplifies the diagnostic process, allowing for rapid and straightforward confirmation of antibiotic resistance in just a matter of minutes, vastly improving upon traditional methods that typically take several days.

In addition, Park has developed a novel "Chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same." This patent focuses on a compound that increases tumor selectivity and efficacy in producing singlet oxygen for photodynamic therapy, providing a promising option for treating malignant tumors. The unique characteristics of this compound position it as a valuable asset in the ongoing fight against cancer.

Career Highlights

Kye Shin Park has built a remarkable career, marked by his tenure at various reputable companies. His professional journey includes significant contributions to Hyundai Electronics Industries Co., Ltd. and Diatech Korea Co., Ltd., where he honed his skills in innovation and research.

Collaborations

During his career, Kye Shin Park has collaborated with talented professionals, including Eun Hee Lee and Hae Sung Park. Their collective expertise has likely contributed to the success of the innovative projects they pursued together in the biomedical field.

Conclusion

Kye Shin Park exemplifies the qualities of a forward-thinking inventor and researcher. His patents not only highlight his technical prowess but also reflect his dedication to addressing critical challenges in healthcare, such as antibiotic resistance and cancer treatment. As he continues to innovate, Kye Shin Park is sure to impact the fields of medicine and technology significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…